EFSCE
CLDX icon

Enterprise Financial Services Corp (EFSC)’s Celldex Therapeutics CLDX Stock Holding History

Enterprise Financial Services Corp (EFSC)’s Portfolio CLDX Stock Details CLDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-90
Closed -$3K – 553
2021
Q2 		$3K Hold
90
– – ﹤0.01% 1036
2021
Q1 		$2K Hold
90
– – ﹤0.01% 1128
2020
Q4 		$2K Hold
90
– – ﹤0.01% 1075
2020
Q3 		$1K Buy
+90
New +$1.05K ﹤0.01% 1163
2016
Q1 		– Sell
-7
Closed -$2K – 1063
2015
Q4 		$2K Buy
+7
New +$1.53K ﹤0.01% 908
2015
Q3 		– Sell
-7
Closed -$3K – 1093
2015
Q2 		$3K Hold
7
– – ﹤0.01% 821
2015
Q1 		$3K Hold
7
– – ﹤0.01% 907
2014
Q4 		$2K Buy
7
+1
+17% +$249 ﹤0.01% 1010
2014
Q3 		$1K Buy
+6
New +$1.31K ﹤0.01% 1117

Other funds holding CLDX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return